Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152


IL-1β regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function.

Elkabets M, Ribeiro VS, Dinarello CA, Ostrand-Rosenberg S, Di Santo JP, Apte RN, Vosshenrich CA.

Eur J Immunol. 2010 Dec;40(12):3347-57. doi: 10.1002/eji.201041037.


Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells.

Park YJ, Song B, Kim YS, Kim EK, Lee JM, Lee GE, Kim JO, Kim YJ, Chang WS, Kang CY.

Cancer Res. 2013 Sep 15;73(18):5669-81. doi: 10.1158/0008-5472.CAN-13-0545. Epub 2013 Jul 18.


Expansion of CD11b(+)Ly6G (+)Ly6C (int) cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions.

Spallanzani RG, Dalotto-Moreno T, Raffo Iraolagoitia XL, Ziblat A, Domaica CI, Avila DE, Rossi LE, Fuertes MB, Battistone MA, Rabinovich GA, Salatino M, Zwirner NW.

Cancer Immunol Immunother. 2013 Dec;62(12):1781-95. doi: 10.1007/s00262-013-1483-x. Epub 2013 Oct 11.


MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.

Finke J, Ko J, Rini B, Rayman P, Ireland J, Cohen P.

Int Immunopharmacol. 2011 Jul;11(7):856-61. doi: 10.1016/j.intimp.2011.01.030. Epub 2011 Feb 11.


Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice.

Lu T, Ramakrishnan R, Altiok S, Youn JI, Cheng P, Celis E, Pisarev V, Sherman S, Sporn MB, Gabrilovich D.

J Clin Invest. 2011 Oct;121(10):4015-29. doi: 10.1172/JCI45862. Epub 2011 Sep 12.


Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells.

Sinha P, Okoro C, Foell D, Freeze HH, Ostrand-Rosenberg S, Srikrishna G.

J Immunol. 2008 Oct 1;181(7):4666-75.


Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells.

Husain Z, Huang Y, Seth P, Sukhatme VP.

J Immunol. 2013 Aug 1;191(3):1486-95. doi: 10.4049/jimmunol.1202702. Epub 2013 Jul 1.


The growing diversity and spectrum of action of myeloid-derived suppressor cells.

Mantovani A.

Eur J Immunol. 2010 Dec;40(12):3317-20. doi: 10.1002/eji.201041170.


Inflammation enhances myeloid-derived suppressor cell cross-talk by signaling through Toll-like receptor 4.

Bunt SK, Clements VK, Hanson EM, Sinha P, Ostrand-Rosenberg S.

J Leukoc Biol. 2009 Jun;85(6):996-1004. doi: 10.1189/jlb.0708446. Epub 2009 Mar 4.


Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.

Mikyšková R, Indrová M, Polláková V, Bieblová J, Símová J, Reiniš M.

J Immunother. 2012 Jun;35(5):374-84. doi: 10.1097/CJI.0b013e318255585a.


Myeloid suppressor cell depletion augments antitumor activity in lung cancer.

Srivastava MK, Zhu L, Harris-White M, Kar UK, Huang M, Johnson MF, Lee JM, Elashoff D, Strieter R, Dubinett S, Sharma S.

PLoS One. 2012;7(7):e40677. doi: 10.1371/journal.pone.0040677. Epub 2012 Jul 16. Erratum in: PLoS One. 2012;7(10). doi:10.1371/annotation/5c756e7d-6e97-416f-836a-dced97cf46af. Kar, Upendra [corrected to Kar, Upendra K].


Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells.

Corzo CA, Cotter MJ, Cheng P, Cheng F, Kusmartsev S, Sotomayor E, Padhya T, McCaffrey TV, McCaffrey JC, Gabrilovich DI.

J Immunol. 2009 May 1;182(9):5693-701. doi: 10.4049/jimmunol.0900092.


Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors.

Beury DW, Parker KH, Nyandjo M, Sinha P, Carter KA, Ostrand-Rosenberg S.

J Leukoc Biol. 2014 Dec;96(6):1109-18. doi: 10.1189/jlb.3A0414-210R. Epub 2014 Aug 28.


Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract.

Sinha P, Ostrand-Rosenberg S.

Cancer Immunol Immunother. 2013 Nov;62(11):1663-73. doi: 10.1007/s00262-013-1470-2. Epub 2013 Aug 27.


Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression.

Bunt SK, Yang L, Sinha P, Clements VK, Leips J, Ostrand-Rosenberg S.

Cancer Res. 2007 Oct 15;67(20):10019-26.


Subsets of myeloid-derived suppressor cells in tumor-bearing mice.

Youn JI, Nagaraj S, Collazo M, Gabrilovich DI.

J Immunol. 2008 Oct 15;181(8):5791-802.


Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.

Schouppe E, Mommer C, Movahedi K, Laoui D, Morias Y, Gysemans C, Luyckx A, De Baetselier P, Van Ginderachter JA.

Eur J Immunol. 2013 Nov;43(11):2930-42. doi: 10.1002/eji.201343349. Epub 2013 Aug 25.


Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy.

Weiss JM, Subleski JJ, Back T, Chen X, Watkins SK, Yagita H, Sayers TJ, Murphy WJ, Wiltrout RH.

J Immunol. 2014 Jun 15;192(12):5821-9. doi: 10.4049/jimmunol.1400404. Epub 2014 May 7.

Items per page

Supplemental Content

Write to the Help Desk